GB9104165D0 - Novel entities for hiv therapy - Google Patents

Novel entities for hiv therapy

Info

Publication number
GB9104165D0
GB9104165D0 GB919104165A GB9104165A GB9104165D0 GB 9104165 D0 GB9104165 D0 GB 9104165D0 GB 919104165 A GB919104165 A GB 919104165A GB 9104165 A GB9104165 A GB 9104165A GB 9104165 D0 GB9104165 D0 GB 9104165D0
Authority
GB
United Kingdom
Prior art keywords
hiv therapy
novel entities
entities
novel
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919104165A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB919104165A priority Critical patent/GB9104165D0/en
Publication of GB9104165D0 publication Critical patent/GB9104165D0/en
Application status is Pending legal-status Critical

Links

GB919104165A 1991-02-27 1991-02-27 Novel entities for hiv therapy Pending GB9104165D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB919104165A GB9104165D0 (en) 1991-02-27 1991-02-27 Novel entities for hiv therapy

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919104165A GB9104165D0 (en) 1991-02-27 1991-02-27 Novel entities for hiv therapy
PCT/GB1992/000341 WO1992015693A1 (en) 1991-02-27 1992-02-26 Chimeric tar enzyme construction for hiv therapy
JP50505592A JPH06505156A (en) 1991-02-27 1992-02-26
EP19920905231 EP0573479A1 (en) 1991-02-27 1992-02-26 Chimeric tar enzyme construction for hiv therapy

Publications (1)

Publication Number Publication Date
GB9104165D0 true GB9104165D0 (en) 1991-04-17

Family

ID=10690703

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919104165A Pending GB9104165D0 (en) 1991-02-27 1991-02-27 Novel entities for hiv therapy

Country Status (4)

Country Link
EP (1) EP0573479A1 (en)
JP (1) JPH06505156A (en)
GB (1) GB9104165D0 (en)
WO (1) WO1992015693A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662896A (en) 1988-03-21 1997-09-02 Chiron Viagene, Inc. Compositions and methods for cancer immunotherapy
US5716826A (en) * 1988-03-21 1998-02-10 Chiron Viagene, Inc. Recombinant retroviruses
US6569679B1 (en) 1988-03-21 2003-05-27 Chiron Corporation Producer cell that generates adenoviral vectors encoding a cytokine and a conditionally lethal gene
US6133029A (en) 1988-03-21 2000-10-17 Chiron Corporation Replication defective viral vectors for infecting human cells
US6241982B1 (en) 1988-03-21 2001-06-05 Chiron Corporation Method for treating brain cancer with a conditionally lethal gene
WO1993008844A1 (en) * 1991-10-30 1993-05-13 Universite Pierre Et Marie Curie (Paris Vi) Transformant cells for the prophylaxis or treatment of diseases caused by viruses, particularly pathogenic retroviruses
US6337209B1 (en) * 1992-02-26 2002-01-08 Glaxo Wellcome Inc. Molecular constructs containing a carcinoembryonic antigen regulatory sequence
WO1994016736A1 (en) * 1993-01-22 1994-08-04 University Research Corporation Localization of therapeutic agents
WO1995014091A2 (en) 1993-11-18 1995-05-26 Chiron Viagene, Inc. Compositions and methods for utilizing conditionally lethal genes
CN1151186A (en) * 1994-05-02 1997-06-04 华盛顿大学 Thymidine kinase mutants
US6451571B1 (en) 1994-05-02 2002-09-17 University Of Washington Thymidine kinase mutants
EP0763123A4 (en) * 1994-06-07 1998-08-12 Immunomedics Inc Safe retroviral vectors, their production and use
EP2132215B1 (en) * 2007-02-28 2015-09-23 The Governors of the University of Alberta Compounds for preventing or treating viral infections and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629892D0 (en) * 1986-12-15 1987-01-28 Wellcome Found Antiviral compounds
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
AU651311B2 (en) * 1988-03-21 1994-07-21 Chiron Corporation Recombinant retroviruses
JP2752788B2 (en) * 1989-01-23 1998-05-18 カイロン コーポレイション Recombinant therapy for infection and hyperproliferative disorders
GB8919607D0 (en) * 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy

Also Published As

Publication number Publication date
JPH06505156A (en) 1994-06-16
EP0573479A1 (en) 1993-12-15
WO1992015693A1 (en) 1992-09-17

Similar Documents

Publication Publication Date Title
DE69216251D1 (en) Substituierte aryl- und heteroaryl-phenyloxazolidinone
DE69224906D1 (en) Thermotropes flüssig-kristallines segment-blockcopolymer
DE69222933D1 (en) Cholangiographiekatheter
DE69228822D1 (en) Intubationsvorrichtung
DE69129193D1 (en) Triterpenderivat
DE69228192D1 (en) Wellpappe-palette
DE69213441D1 (en) Analsphinkterprothese
GB2242633B (en) Resuscitator
GB2257579B (en) Pin-header
DE69222628D1 (en) Wärmeisolationsmaterial
DE69228486D1 (en) Thrombosefilter
GB9126297D0 (en) Medicaments
IL102204D0 (en) Therapeutic preparations
GB9114760D0 (en) Therapeutic agents
GB9126260D0 (en) Therapeutic agents
GB9121028D0 (en) Therapeutic agents
GB9024365D0 (en) Medicaments
AP9000234A0 (en) Therapeutic nucleocides
ZA9103282B (en) Dosage form
GR3018544T3 (en) Benzamides
PL307567A1 (en) Novel glucane preparation
PH30343A (en) Novel 9-amino-7-substituted-6-demethyl-6-deoxytetracyclines
IL104170D0 (en) Therapeutic agents
CY1943A (en) Piperazinyl-and piperidinyl-cyclohexanols
GB9119704D0 (en) Therapeutic agents